These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1639502)

  • 1. A novel murine model of disseminated trichosporonosis.
    Gokaslan A; Anaissie E
    Infect Immun; 1992 Aug; 60(8):3339-44. PubMed ID: 1639502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental fusarial hyalohyphomycosis in a murine model.
    Legrand C; Anaissie E; Hashem R; Nelson P; Bodey GP; Ro J
    J Infect Dis; 1991 Nov; 164(5):944-8. PubMed ID: 1940473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disseminated trichosporonosis in a neutropenic murine model.
    Hospenthal D; Belay T; Lappin P; Rogers A; Kennedy M
    Mycopathologia; 1993 May; 122(2):115-22. PubMed ID: 8327000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity.
    Anaissie E; Hachem R; K-Tin-U C; Stephens LC; Bodey GP
    Infect Immun; 1993 Apr; 61(4):1268-71. PubMed ID: 8454330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenicity of Trichosporon asahii in a murine model of disseminated trichosporonosis.
    Yang RY; Wang WL; Ao JH; Hao ZF; Zhang J; Wang CM
    Chin Med J (Engl); 2008 Dec; 121(24):2557-60. PubMed ID: 19187595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated trichosporonosis in a murine model of chronic granulomatous disease.
    Lacy SH; Gardner DJ; Olson LC; Ding L; Holland SM; Bryant MA
    Comp Med; 2003 Jun; 53(3):303-8. PubMed ID: 12868577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of amphotericin B and azoles alone and in combination against disseminated trichosporonosis in neutropenic mice.
    Kamberi P; Atsuro H; Takayoshi T; Masaru N
    Chemotherapy; 1998; 44(1):55-62. PubMed ID: 9444410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental model of progressive disseminated trichosporonosis in mice with latent trichosporonemia.
    Yamagata E; Kamberi P; Yamakami Y; Hashimoto A; Nasu M
    J Clin Microbiol; 2000 Sep; 38(9):3260-6. PubMed ID: 10970368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disseminated Trichosporon beigelii infection: report of nine cases and review].
    Tashiro T; Nagai H; Yamasaki T; Goto Y; Akizuki S; Nasu M
    Kansenshogaku Zasshi; 1993 Aug; 67(8):704-11. PubMed ID: 8409577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of disseminated Trichosporon beigelii infection in a patient with myelodysplastic syndrome after chemotherapy.
    Kim JC; Kim YS; Park CS; Kang JM; Kim BN; Woo JH; Ryu J; Kim WG
    J Korean Med Sci; 2001 Aug; 16(4):505-8. PubMed ID: 11511798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacies of amphotericin B, triazoles, and combination of both as experimental therapy for murine trichosporonosis.
    Anaissie EJ; Hachem R; Karyotakis NC; Gokaslan A; Dignani MC; Stephens LC; Tin-U CK
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2541-4. PubMed ID: 7872744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azole therapy for trichosporonosis: clinical evaluation of eight patients, experimental therapy for murine infection, and review.
    Anaissie E; Gokaslan A; Hachem R; Rubin R; Griffin G; Robinson R; Sobel J; Bodey G
    Clin Infect Dis; 1992 Nov; 15(5):781-7. PubMed ID: 1445976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental pathogenicity of a clinical isolate of Trichosporon dermatis in a murine model.
    Lin YP; Yang YP; Huang WM; Chen YH; Li SF; Fan YM
    Mycopathologia; 2011 Nov; 172(5):381-7. PubMed ID: 21750940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasive Trichosporon beigelii infection in immunosuppressed rats.
    Dörlemann A; Listemann H; Iglauer F
    Mycoses; 1994; 37(3-4):109-16. PubMed ID: 7845415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated Trichosporon beigelii infection after orthotopic liver transplantation.
    Ness MJ; Markin RS; Wood RP; Shaw BW; Woods GL
    Am J Clin Pathol; 1989 Jul; 92(1):119-23. PubMed ID: 2665472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathogenesis of Trichosporon asahii and strategies for infectious control of disseminated trichosporonosis].
    Tokimatsu I; Karashima R; Yamagata E; Yamakami Y; Nagai H; Kadota J; Nasu M
    Nihon Ishinkin Gakkai Zasshi; 2003; 44(3):181-6. PubMed ID: 12913806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trichosporon beigelii: a life-threatening pathogen in immunocompromised hosts.
    Erer B; Galimberti M; Lucarelli G; Giardini C; Polchi P; Baronciani D; Gaziev D; Angelucci E; Izzi G
    Bone Marrow Transplant; 2000 Apr; 25(7):745-9. PubMed ID: 10745260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental murine model of disseminated Pseudallescheria infection.
    González GM; Tijerina R; Najvar L; Rinaldi M; Yeh IT; Graybill JR
    Med Mycol; 2002 Jun; 40(3):243-8. PubMed ID: 12146753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activities of D0870, a novel triazole, against Candida lusitaniae and Trichosporon beigelii in experimental murine infections.
    Karyotakis NC; Dignani MC; Hachem R; Anaissie EJ
    Antimicrob Agents Chemother; 1995 Feb; 39(2):571-3. PubMed ID: 7726538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disseminated Trichosporon beigelii infection in patients with malignant diseases: immunohistochemical study and review.
    Tashiro T; Nagai H; Kamberi P; Goto Y; Kikuchi H; Nasu M; Akizuki S
    Eur J Clin Microbiol Infect Dis; 1994 Mar; 13(3):218-24. PubMed ID: 8050434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.